Your browser doesn't support javascript.
loading
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.
Wang, Menglin; Rousseau, Benoit; Qiu, Kunyu; Huang, Guannan; Zhang, Yu; Su, Hang; Le Bihan-Benjamin, Christine; Khati, Ines; Artz, Oliver; Foote, Michael B; Cheng, Yung-Yi; Lee, Kuo-Hsiung; Miao, Michael Z; Sun, Yue; Bousquet, Philippe-Jean; Hilmi, Marc; Dumas, Elise; Hamy, Anne-Sophie; Reyal, Fabien; Lin, Lin; Armistead, Paul M; Song, Wantong; Vargason, Ava; Arthur, Janelle C; Liu, Yun; Guo, Jianfeng; Zhou, Xuefei; Nguyen, Juliane; He, Yongqun; Ting, Jenny P-Y; Anselmo, Aaron C; Huang, Leaf.
Afiliação
  • Wang M; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  • Rousseau B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Qiu K; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  • Huang G; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Zhang Y; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
  • Su H; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
  • Le Bihan-Benjamin C; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  • Khati I; Department of Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, NC, USA.
  • Artz O; Health Data and Assessment Department, Data Science and Assessment Division, French National Cancer Institute, Boulogne-Billancourt, France.
  • Foote MB; Health Data and Assessment Department, Data Science and Assessment Division, French National Cancer Institute, Boulogne-Billancourt, France.
  • Cheng YY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lee KH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Miao MZ; Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  • Sun Y; Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  • Bousquet PJ; Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan.
  • Hilmi M; Curriculum in Oral and Craniofacial Biomedicine, Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina, Chapel Hill, NC, USA.
  • Dumas E; Thurston Arthritis Research Center, Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, USA.
  • Hamy AS; Department of Radiology and Biomedical Research Imaging Center, University of North Carolina, Chapel Hill, NC, USA.
  • Reyal F; Health Survey, Data Science and Assessment Division, French National Cancer Institute, Boulogne Billancourt, France.
  • Lin L; GERCOR Group, Paris, France.
  • Armistead PM; Medical Oncology Department, Curie Institute, Saint Cloud, France.
  • Song W; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.
  • Vargason A; INSERM, U900, Paris, France.
  • Arthur JC; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France.
  • Liu Y; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.
  • Guo J; Department of Medical Oncology, Centre René Hughenin, Saint Cloud, France.
  • Zhou X; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.
  • Nguyen J; Department of Surgery, Institut Jean Godinot, Reims, France.
  • He Y; Department of Surgical Oncology, Institut Curie, University of Paris, Paris, France.
  • Ting JP; BMTCT Program, Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Anselmo AC; BMTCT Program, Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Huang L; Department of Internal Medicine, University of North Carolina, Chapel Hill, NC, USA.
Nat Biotechnol ; 2023 Sep 25.
Article em En | MEDLINE | ID: mdl-37749267

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos